Mangafodipir trisodium

The trisodium salt of mangafodipir with potential antioxidant and chemoprotective activities. Consisting of manganese (II) ions chelated to fodipir… (More)
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

MANGAFODIPIR

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Hepatobiliary-specific contrast agents are one of several classes of contrast agents available for magnetic resonance (MR… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2004
2004
Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.
OBJECTIVE This study was designed to determine whether the addition of mangafodipir trisodium-enhanced MRI could improve the… (More)
Is this relevant?
2004
2004
Biliary tract depiction in living potential liver donors comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography: Initial experience
PURPOSE To compare biliary tract depiction in living potential liver donors at conventional magnetic resonance (MR), mangafodipir… (More)
Is this relevant?
2002
2002
Diagnosis and staging of pancreatic cancer: Comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT
OBJECTIVE The purpose of this study was to compare mangafodipir trisodium-enhanced MR imaging performed with a phased array coil… (More)
Is this relevant?
2002
2002
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography.
OBJECTIVE The purpose of our study was to assess the usefulness of mangafodipir trisodium-enhanced MR cholangiography for… (More)
Is this relevant?
1999
1999
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging
The aim of this work was to study the ability of mangafodipir trisodium (Mn-DPDP)-enhanced MR imaging in differentiating… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
Uptake of mangafodipir trisodium in liver metastases from endocrine tumors.
The purpose of the study was to investigate retrospectively whether mangafodipir trisodium (MnDPDP) can enhance the liver… (More)
Is this relevant?
1998
1998
Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium.
Inflammatory pseudotumor of the liver is a rare benign mass that is often misdiagnosed as hepatocellular carcinoma at… (More)
Is this relevant?
1996
1996
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
PURPOSE To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at… (More)
Is this relevant?
1995
1995
Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats.
Mangafodipir trisodium (MnDPDP) is a manganese chelate being developed as a contrast agent for magnetic resonance imaging of the… (More)
Is this relevant?